Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Más filtros











Base de datos
Intervalo de año de publicación
1.
Vet Comp Oncol ; 15(1): 105-117, 2017 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-25702795

RESUMEN

Kinetic parameter variability may be sensitive to kinetic model choice, kinetic model implementation or patient-specific effects. The purpose of this study was to assess their impact on the variability of dynamic contrast-enhanced computed tomography (DCE-CT) kinetic parameters. A total of 11 canine patients with sinonasal tumours received high signal-to-noise ratio, test-double retest DCE-CT scans. The variability for three distributed parameter (DP)-based models was assessed by analysis of variance. Mixed-effects modelling evaluated patient-specific effects. Inter-model variability (CVinter ) was comparable to or lower than intra-model variability (CVintra ) for blood flow (CVinter :[4-28%], CVintra :[28-31%]), fractional vascular volume (CVinter :[3-17%], CVintra :[16-19%]) and permeability-surface area product (CVinter :[5-12%], CVintra :[14-15%]). The kinetic models were significantly (P<0.05) impacted by patient characteristics for patient size, area underneath the curve of the artery and of the tumour. In conclusion, DP-based models demonstrated good agreement with similar differences between models and scans. However, high variability in the kinetic parameters and their sensitivity to patient size may limit certain quantitative applications.


Asunto(s)
Carcinoma/veterinaria , Enfermedades de los Perros/diagnóstico por imagen , Enfermedades de los Perros/fisiopatología , Neoplasias de los Senos Paranasales/veterinaria , Sarcoma/veterinaria , Tomografía Computarizada por Rayos X/veterinaria , Análisis de Varianza , Animales , Carcinoma/fisiopatología , Medios de Contraste , Perros , Cinética , Neoplasias de los Senos Paranasales/diagnóstico por imagen , Neoplasias de los Senos Paranasales/fisiopatología , Sarcoma/fisiopatología , Tomografía Computarizada por Rayos X/métodos
2.
Brain Res ; 858(2): 356-62, 2000 Mar 10.
Artículo en Inglés | MEDLINE | ID: mdl-10708687

RESUMEN

3-nitropropionic acid (3-NP) administered systemically daily for 4 days to rats inhibits mitochondrial oxidative phosphorylation and induces selective lesions in the striatum in a manner reminiscent of Huntington's disease (HD). To investigate the potential oxidative nature of these lesions, rats were injected with 3-NP (20 mg/kg, i.p. daily for 4 days) and subsequently isolated brain synaptosomal membranes were examined for evidence of oxidative stress. Brain synaptosomal membrane proteins from rats injected with 3-NP exhibited a decreased in W/S ratio, the relevant electron paramagnetic resonance (EPR) parameter used to determine levels of protein oxidation (76% of control), and Western blot analysis for protein carbonyls revealed direct evidence of increased synaptosomal membrane protein oxidation (248% of control). Similar results were obtained in synaptosomes isolated from striatum and from cerebral cortex, demonstrating that the oxidative changes are not restricted to the lesion site. Moreover, increased oxidative stress was evident prior to the appearance of morphological lesions. These data are consistent with the hypothesis that 3-NP-induced striatal lesions, and perhaps those in HD, are associated with oxidative processes.


Asunto(s)
Convulsivantes/farmacología , Enfermedad de Huntington/metabolismo , Propionatos/farmacología , Sinaptosomas/efectos de los fármacos , Sinaptosomas/metabolismo , Animales , Western Blotting , Corteza Cerebral/metabolismo , Cuerpo Estriado/metabolismo , Óxidos N-Cíclicos , Masculino , Proteínas del Tejido Nervioso/análisis , Proteínas del Tejido Nervioso/metabolismo , Nitrocompuestos , Oxidación-Reducción , Estrés Oxidativo/efectos de los fármacos , Estrés Oxidativo/fisiología , Ratas , Ratas Sprague-Dawley , Marcadores de Spin
3.
Neurochem Int ; 36(3): 185-91, 2000 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-10676851

RESUMEN

Glutathione deficiency has been associated with a number of neurodegenerative diseases including Lou Gehrig's disease, Parkinson's disease, and HIV. A crucial role for glutathione is as a free radical scavenger. Alzheimer's disease (AD) brain is characterized by oxidative stress, manifested by protein oxidation, lipid oxidation, oxidized glutathione, and decreased activity of glutathione S-transferase, among others. Reasoning that elevated levels of endogenous glutathione would offer protection against free radical-induced oxidative stress, rodents were given in vivo injections of N-acetylcysteine (NAC), a known precursor of glutathione, to study the vulnerability of isolated synaptosomal membranes treated with Fe2+/H2O2, a known hydroxyl free radical producer. Protein carbonyls, a marker of protein oxidation, were measured. NAC significantly increased endogenous glutathione levels in cortical synaptosome cytosol (P < 0.01). As reported previously, protein carbonyl levels of the Fe2+/H2O2-treated synaptosomes were significantly higher compared to that of non-treated controls (P < 0.01), consistent with increased oxidative stress. In contrast, protein carbonyl levels in Fe2+/H2O2-treated synaptosomes isolated from NAC-injected animals were not significantly different from saline-injected non-treated controls, demonstrating protection against hydroxyl radical induced oxidative stress. These results are consistent with the notion that methods to increase endogenous glutathione levels in neurodegenerative diseases associated with oxidative stress, including AD, may be promising.


Asunto(s)
Encéfalo/metabolismo , Glutatión/metabolismo , Radical Hidroxilo/farmacología , Proteínas del Tejido Nervioso/metabolismo , Estrés Oxidativo , Acetilcisteína/farmacología , Animales , Encéfalo/efectos de los fármacos , Compuestos Ferrosos/farmacología , Peróxido de Hidrógeno/farmacología , Masculino , Oxidación-Reducción , Ratas , Ratas Sprague-Dawley , Sinaptosomas/metabolismo
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA